A novel insulin analog with unique properties: [Lys.sup.B3], [Glu.sup.B29] insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1

The potentially enhanced mitogenic activity of insulin analogs represents a safety risk that requires detailed analysis of new analogs considered for therapeutic applications. We assessed the signaling properties and mitogenic potency of two novel rapid-acting insulin analogs, [Lys.sup.B3],[Glu.sup....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2003-09, Vol.52 (9), p.2227
Hauptverfasser: Rakatzi, Irini, Ramrath, Stefanie, Ledwig, Daniela, Dransfeld, Olaf, Bartels, Thomas, Seipke, Gerhard, Eckel, Jurgen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!